A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/00 (2006.01) C07K 16/28 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2294154
Methods and compositions for inhibiting rejection of insulin-producing tissue in a graft recipient, as well as methods and compositions for prolonging graft survival or function; for reversing graft rejection or restoring function of an impaired graft; and, for inducing immunological tolerance to grafted, insulin-producing tissue. The present methods and compositions are suitable for treatment or prophylaxis of defects in metabolic control of blood glucose homeostasis, including defects manifested as diabetes melitus (DM).
L'invention concerne des procédés et des compositions destinés à inhiber le rejet d'un tissu sécrétant de l'insuline chez un receveur. L'invention concerne également des procédés et des compositions visant: à prolonger la survie ou la fonction d'un greffon; à inverser le rejet de greffon ou à rétablir la fonction d'un greffon altéré; et à induire la tolérance immunologique à un tissu greffé sécrétant de l'insuline. Les présents procédés et les présentes compositions conviennent particulièrement au traitement ou à la prophylaxie d'anomalies intervenant dans la régulation métabolique de l'homéostasie glycémique, notamment les anomalies se manifestant sous forme de diabète sucré (DM).
Burkly Linda
Kenyon Norma S.
Ricordi Camillo
Thomas David W.
Biogen Inc.
Biogen Idec Ma Inc.
Smart & Biggar
University Of Miami
LandOfFree
Cd154 blockade therapy for pancreatic islet tissue... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cd154 blockade therapy for pancreatic islet tissue..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cd154 blockade therapy for pancreatic islet tissue... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1808708